Ask AI

Comprehensive Patient-Centric Care in Multiple Myeloma: Experts Unpack Challenges, Clinical Considerations, and Strategies to Optimize Care for Patients Treated With Bispecific Antibodies

Enhance your understanding of the safety and efficacy of bispecific antibodies used to treat patients with multiple myeloma to optimize outcomes through a certified roundtable video module, expert-written ClinicalThought commentary, certified text modules, and accompanying downloadable slides.

Share

Program Content

Activities

BsAbs in Multiple Myeloma
Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma: A Roundtable of Considerations and Strategies for Implementation Into Clinical Practice
Video
Congratulations: You achieved a completion on 04/09/2022

Released: October 15, 2025

Expires: April 14, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson